IND-6, a highly divergent IND-type metallo-β-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4320-4326

  Zeba, Boukaré ^a   De Luca, Filomena ^b   Dubus, Alain ^c   Delmarcelle, Michael ^c   Simporé, Jacques ^a,d   Nacoulma, Odile G ^a   Rossolini, Gian Maria ^b   Frère, Jean Marie ^c   Docquier, Jean Denis ^b  

^a UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Centre Medical Saint Camille (CMSC)   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; IND 6 PROTEIN; MEROPENEM; METALLO BETA LACTAMASE; NORFLOXACIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PYROGLUTAMIC ACID; TEMOCILLIN; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BURKINA FASO; CHRYSEOBACTERIUM INDOLOGENES; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PURIFICATION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROCESSING; SEQUENCE ANALYSIS; TURNOVER TIME;

ADULT; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CEPHALEXIN; CEPHALOSPORINS; CEPHALOTHIN; CHRYSEOBACTERIUM; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 70349349056     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01607-08     Document Type: Article

References (35)

1. Akay, M., E. Gunduz, and Z. Gulbas. 2006. Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient. Bone Marrow Transplant. 37:435-436.
2. Arnold, K., L. Bordoli, J. Kopp, and T. Schwede. 2006. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195-201. (Pubitemid 43205406)
3. Bayraktar, M. R., E. Aktas, Y. Ersoy, A. Cicek, and R. Durmaz. 2007. Postoperative Chryseobacterium indologenes bloodstream infection caused by contamination of distillate water. Infect. Control Hosp. Epidemiol. 28:368-369.
4. Bellais, S., D. Aubert, T. Naas, and P. Nordmann. 2000. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum. Antimicrob. Agents Chemother. 44: 1878-1886.
5. Bellais, S., D. Girlich, A. Karim, and P. Nordmann. 2002. EBR-1, a novel Ambler subclass B1 β-lactamase from Empedobacter brevis. Antimicrob. Agents Chemother. 46:3223-3227.
6. Bellais, S., S. Leotard, L. Poirel, T. Naas, and P. Nordmann. 1999. Molecular characterization of a carbapenem-hydrolyzing β-lactamase from Chryseobacterium (Flavobacterium) indologenes. FEMS Microbiol. Lett. 171:127-132. (Pubitemid 29094671)
7. Bellais, S., T. Naas, and P. Nordmann. 2002. Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing β-lactamase from Chryseobacterium gleum. Antimicrob. Agents Chemother. 46:2791-2796. (Pubitemid 34898655)
8. Bellais, S., L. Poirel, S. Leotard, T. Naas, and P. Nordmann. 2000. Genetic diversity of carbapenem-hydrolyzing metallo-β-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob. Agents Chemother. 44: 3028-3034. (Pubitemid 30803061)
9. Borgianni, L., J. M. Frere, G. M. Rossolini, and J. D. Docquier. 2006. Mutational analysis of the VIM-2 active site: role of positions 64 and 87 in enzyme activity and stability, abstr. C1-28, p. 63-64. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA.
10. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 7th ed. CLSI document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Docquier, J. D., J. Lamotte-Brasseur, M. Galleni, G. Amicosante, J. M. Frere, and G. M. Rossolini. 2003. On functional and structural heterogeneity of VIM-type metallo-β-lactamases. J. Antimicrob. Chemother. 51:257-266.
12. Docquier, J. D., F. Pantanella, F. Giuliani, M. C. Thaller, G. Amicosante, M. Galleni, J. M. Frere, K. Bush, and G. M. Rossolini. 2002. CAU-1, a subclass B3 metallo-β-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome. Antimicrob. Agents Chemother. 46:1823-1830.
13. Galleni, M., J. Lamotte-Brasseur, G. M. Rossolini, J. Spencer, O. Dideberg, and J. M. Frere. 2001. Standard numbering scheme for class B β-lactamases. Antimicrob. Agents Chemother. 45:660-663.
14. Garcia-Saez, I., J. Hopkins, C. Papamicael, N. Franceschini, G. Amicosante, G. M. Rossolini, M. Galleni, J. M. Frere, and O. Dideberg. 2003. The 1.5-Å structure of Chryseobacterium meningosepticum zinc β-lactamase in complex with the inhibitor, D-captopril. J. Biol. Chem. 278:23868-23873.
15. Green, B. T., and P. E. Nolan. 2001. Cellulitis and bacteraemia due to Chryseobacterium indologenes. J. Infect. 42:219-220.
16. Hernandez-Valladeres, M., A. Felici, G. Weber, H. W. Adolph, M. Zeppezauer, G. M. Rossolini, G. Amicosante, J. M. Frere, and M. Galleni. 1997. Zn(II) dependence of the Aeromonas hydraphila AE036 metallo-β-lactamase activity and stability. Biochemistry 36:11534-11541.
17. Hsueh, P. R., L. J. Teng, P. C. Yang, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1997. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 16:568-574.
18. IND metallo-β-lactamase-producing Chryseobacterium indologenes isolates detected in Hefei, China. Int. J. Antimicrob. Agents 32:398-400.
19. Mammeri, H., S. Bellais, and P. Nordmann. 2002. Chromosome-encoded β-lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1 metalloenzymes. Antimicrob. Agents Chemother. 46:3561-3567.
20. Matsumura, N., S. Minami, Y. Watanabe, S. Iyobe, and S. Mitsuhashi. 1999. Role of permeability in the activities of β-lactams against gram-negative bacteria which produce a group 3 β-lactamase. Antimicrob. Agents Chemtoher. 43:2084-2086.
21. Naas, T., S. Bellais, and P. Nordmann. 2003. Molecular and biochemical characterization of a carbapenem-hydrolysing β-lactamase from Flavobacterium johnsoniae. J. Antimicrob. Chemother. 51:267-273.
22. Pan, H. J., L. J. Teng, Y. C. Chen, P. R. Hsueh, P. C. Yang, S. W. Ho, and K. T. Luh. 2000. High protease activity of Chryseobacterium indologenes isolates associated with invasive infection. J. Microbiol. Immunol. Infect. 33:223-226.
23. Perilli, M., B. Caporale, G. Celenza, C. Pellegrini, J. D. Docquier, M. Mezzatesta, G. M. Rossolini, S. Stefani, and G. Amicosante. 2007. Identification and characterization of a new metallo-β-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes. Antimicrob. Agents Chemother. 51:2988-2990.
24. Ray, P., K. Sharma, and V. Gautam. 2005. Chryseobacterium indologenes bacteremia: a case report. J. Commun. Dis. 37:259-260.
25. Reynaud, I., V. Chanteperdrix, C. Broux, P. Pavese, J. Croize, M. Maurin, J. P. Stahl, and C. Jacquot. 2007. A severe form of Chryseobacterium indologenes pneumonia in an immunocompetent patient. Med. Mal. Infect. 37:762-764.
26. Rossolini, G. M., and J. D. Docquier. 2007. Class B β-lactamases, p. 115-144. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
27. Rossolini, G. M., N. Franceschini, M. L. Riccio, P. S. Mercuri, M. Perilli, M. Galleni, J. M. Frere, and G. Amicosante. 1998. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B β-lactamase showing a broad substrate profile. Biochem. J. 332(Pt. 1):145-152.
28. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Schilling, S., C. Wasternack, and H. U. Demuth. 2008. Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution. Biol. Chem. 389:983-991.
30. Schreckenberger, P. C., M. I. Daneshvar, and D. G. Hollis. 2007. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods, p. 770-802. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
31. Studier, F. W. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41:207-234.
32. Tomatis, P. E., R. M. Rasia, L. Segovia, and A. J. Vila. 2005. Mimicking natural evolution in metallo-β-lactamases through second-shell ligand mutations. Proc. Natl. Acad. Sci. USA 102:13761-13766.
33. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo- β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
34. Wang, S. L., W. T. Hsu, T. W. Liang, Y. H. Yen, and C. L. Wang. 2008. Purification and characterization of three novel keratinolytic metalloproteases produced by Chryseobacterium indologenes TKU014 in a shrimp shell powder medium. Bioresour. Technol. 99:5679-5686.
35. Zeba, B., P. J. Simpore, O. G. Nacoulma, and J. M. Frere. 2005. Identification of metallo-β-lactamase from a clinical isolate at Saint Camille Hospital Center of Ouagadougou/Burkina Faso. Afr. J. Biotechnol. 4:286-288.